Fibrosis and inflammatory mediated musculoskeletal disease accounts for a significant portion of medical disability across all age groups genders and socioeconomic status.  Access to effective treatments is hindered by expense and mode of administration. Far too often , treatment is delayed due to these factors resulting in an unnecessary increase in impairment. Extensor Bio, Inc. is working to meet the need for cost effective treatment with rapid onset of action resulting in a high degree of patient and provider satisfaction.